Latest update February 6th, 2025 7:27 AM
Sep 06, 2020 News
The Ministry of Health (MOH) is examining the options for COVID -19 vaccinations.
During a virtual press conference held on Friday, Minister of Health Dr. Frank Anthony has said that the government is engaging Russia to access the COVID-19 vaccine, Sputnik V, from that country if it proves to be successful in fighting off the deadly virus.
Dr. Anthony noted the government is in talks with a number of countries to explore its options once the vaccines become available.
As such, Dr Anthony stressed that the engagement does not mean a decision has been made to buy the vaccine but that if another round of trials proves that it can be used, then Guyana wants to be able to have it as an option.
“Many other vaccines are being developed. What we want to do is understand the vaccine they are offering – how it works, the science behind it – and if it is proven to be effective, then we’ll make those decisions as we go. But I think it is important that we engage early so that we have many options to choose from,” he added.
According to the Minister the initial discussion has begun with the Russian embassy in Guyana.
He noted that the reviews have so far shown that the vaccine is safe but the Government will await the Phase 3 trials to see how it turns out.
Dr. Anthony said that on Thursday a Ministry of Health team would engage with the Russian Government in a tele-conference to learn more about the particular vaccine.
In addition, Dr. Anthony said that his Ministry is in discussions with Global Vaccine Alliance (GAVI) to explore the other options available.
GAVI has been in contact with PAHO and UNICEF together they have been leading efforts to procure and supply vaccines, as part of the global vaccine plan of the COVID-19 Vaccine Global Access Facility (COVAX Facility).
With several vaccine candidates showing promise, UNICEF outlined in a statement that it is working in collaboration with the PAHO Revolving Fund to lead efforts to procure and supply doses of COVID-19 vaccines on behalf of the COVAX Facility for 92 low- and lower-middle-income countries which vaccine purchases will be supported by the mechanism through the GAVI COVAX AMC as well as a buffer stockpile for humanitarian emergencies.
As such, UNICEF will also serve as procurement coordinator to support procurement by 80 higher-income economies, which have expressed their intent to participate in the COVAX Facility and would finance the vaccines from their own public finance budgets.
UNICEF will undertake these efforts in close collaboration with WHO, GAVI, CEPI, PAHO, World Bank, the Bill and Melinda Gates Foundation, and other partners.
The COVAX Facility is open to all countries to ensure that no country is left without access to a future COVID-19 vaccine.
Meanwhile, Henrietta Fore, UNICEF Executive Director noted that “This is an all hands on deck the partnership between governments, manufacturers, and multilateral partners to continue the high-stakes fight against the COVID-19 pandemic.”
“In our collective pursuit of a vaccine, UNICEF is leveraging its unique strengths in vaccine supply to make sure that all countries have safe, fast, and equitable access to the initial doses when they are available,” She said.
Feb 06, 2025
-Jaikarran, Bookie, Daniram amongst the runs Kaieteur Sports-The East Bank Demerara Cricket Association/D&R Construction and Machinery Rental 40-Over Cricket Competition, which began on January...Peeping Tom… Kaieteur News-The American humorist Will Rogers once remarked that the best investment on earth is earth... more
Antiguan Barbudan Ambassador to the United States, Sir Ronald Sanders By Sir Ronald Sanders Kaieteur News- The upcoming election... more
Freedom of speech is our core value at Kaieteur News. If the letter/e-mail you sent was not published, and you believe that its contents were not libellous, let us know, please contact us by phone or email.
Feel free to send us your comments and/or criticisms.
Contact: 624-6456; 225-8452; 225-8458; 225-8463; 225-8465; 225-8473 or 225-8491.
Or by Email: [email protected] / [email protected]